Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0000950170-24-114387

Options or other derivatives

  • General Counsel acquired 15,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Winslow Garrett General Counsel 2024-10-09 Grant or award · Stock Option (right to buy) +15,600 15,600 D
Loading xslF345X05/ownership.xml…